CIK 0001370053
- Non-accelerated filer
- Smaller reporting company
ANAPTYSBIO, INC
Sign in to watch- Ticker
- ANAB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 203828755
- Phone
- +1 858-362-6295
- Business address
- 10770 WATERIDGE CIRCLE, SUITE 210, SAN DIEGO, CA, 92121
- Former names
- ANAPTYSBIO INC, ANAPTYS BIOSCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $249,372
- in 1 filing, $249K under 10b5-1 plans
Net −$249,372. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 67 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-11-01 | Suria Hamza President, CEO | Exercise or conversion | +36,646 | $1.12 | $41K | 104,282 |
| 2021-11-01 | Suria Hamza President, CEO | Sale | −34,087 | $32.27 | $1.1M | 70,195 |
| 2021-11-01 | Suria Hamza President, CEO | Sale | −2,559 | $32.88 | $84K | 67,636 |
| 2021-11-01 | Suria Hamza President, CEO | Exercise or conversion · Employee Stock Option (right to buy) | −36,646 | 36,645 | ||
| 2021-10-26 | Suria Hamza President, CEO | Exercise or conversion | +15,993 | $1.12 | $18K | 83,629 |
| 2021-10-26 | Suria Hamza President, CEO | Sale | −15,993 | $30.00 | $480K | 67,636 |
| 2021-10-26 | Suria Hamza President, CEO | Exercise or conversion · Employee Stock Option (right to buy) | −15,993 | 73,291 | ||
| 2021-09-17 | Suria Hamza President, CEO | Exercise or conversion | +10,000 | $1.12 | $11K | 67,636 |
| 2021-09-17 | Suria Hamza President, CEO | Exercise or conversion · Employee Stock Option (right to buy) | −10,000 | 20,361 | ||
| 2021-05-12 | Suria Hamza President, CEO | Exercise or conversion | +10,000 | $1.12 | $11K | 57,636 |
| 2021-05-12 | Suria Hamza President, CEO | Exercise or conversion · Employee Stock Option (right to buy) | −10,000 | 30,361 | ||
| 2021-05-04 | EcoR1 Capital, LLC Director | Purchase | +165,000 | $23.25 | $3.8M | 7,520,424 |
| 2021-05-03 | EcoR1 Capital, LLC Director | Purchase | +20,800 | $23.31 | $485K | 7,355,424 |
| 2021-04-30 | EcoR1 Capital, LLC Director | Purchase | +35,700 | $23.16 | $827K | 7,334,624 |
| 2021-04-27 | EcoR1 Capital, LLC Director | Purchase | +33,800 | $23.82 | $805K | 7,298,924 |
| 2021-04-26 | EcoR1 Capital, LLC Director | Purchase | +13,900 | $23.80 | $331K | 7,265,124 |
| 2021-04-23 | EcoR1 Capital, LLC Director | Purchase | +99,600 | $23.54 | $2.3M | 7,251,224 |
| 2021-03-09 | EcoR1 Capital, LLC 10% owner | Purchase | +531,000 | $18.70 | $9.9M | 7,151,624 |
| 2021-03-08 | EcoR1 Capital, LLC 10% owner | Purchase | +2,777,800 | $18.97 | $52.7M | 6,620,624 |
| 2021-02-23 | EcoR1 Capital, LLC 10% owner | Purchase | +29,500 | $25.48 | $752K | 3,842,824 |
Page 24 of 27 · 522 trades